BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 12296636)

  • 1. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage.
    Mocco J; Mack WJ; Kim GH; Lozier AP; Laufer I; Kreiter KT; Sciacca RR; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Sep; 97(3):537-41. PubMed ID: 12296636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage.
    Mack WJ; Mocco J; Hoh DJ; Huang J; Choudhri TF; Kreiter KT; Lozier A; Opperman M; Poisik A; Yorgason J; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Jan; 96(1):71-5. PubMed ID: 11794607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
    J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.
    Kaynar MY; Tanriverdi T; Kafadar AM; Kacira T; Uzun H; Aydin S; Gumustas K; Dirican A; Kuday C
    J Neurosurg; 2004 Dec; 101(6):1030-6. PubMed ID: 15597765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
    Veyna RS; Seyfried D; Burke DG; Zimmerman C; Mlynarek M; Nichols V; Marrocco A; Thomas AJ; Mitsias PD; Malik GM
    J Neurosurg; 2002 Mar; 96(3):510-4. PubMed ID: 11883835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma acrolein levels and their association with delayed ischemic neurological deficits following aneurysmal subarachnoid haemorrhage: a pilot study.
    Garrett MC; McCullough-Hicks ME; Kim GH; Komotar RJ; Kellner CP; Hahn DK; Otten ML; Rynkowski MA; Merkow MB; Starke RM; Connolly ES
    Br J Neurosurg; 2008 Aug; 22(4):546-9. PubMed ID: 18686065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE
    J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasospasm after SAH due to aneurysm rupture of the anterior circle of Willis: value of TCD monitoring.
    Fontanella M; Valfrè W; Benech F; Carlino C; Garbossa D; Ferrio M; Perez R; Berardino M; Bradac G; Ducati A
    Neurol Res; 2008 Apr; 30(3):256-61. PubMed ID: 17767811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article.
    Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS
    Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage.
    Beadell NC; Thompson EM; Delashaw JB; Cetas JS
    J Neurosurg; 2012 Oct; 117(4):781-6. PubMed ID: 22920957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.
    Juvela S
    J Neurosurg; 2000 Mar; 92(3):390-400. PubMed ID: 10701524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303.
    Lin CL; Kwan AL; Dumont AS; Su YF; Kassell NF; Wang CJ; Wu SC; Kuo CL; Huang CS; Jeng AY; Liu CS
    J Neurosurg; 2007 Mar; 106(3):442-8. PubMed ID: 17367067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits.
    Rothoerl RD; Schebesch KM; Kubitza M; Woertgen C; Brawanski A; Pina AL
    Cerebrovasc Dis; 2006; 22(2-3):143-9. PubMed ID: 16691023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage.
    Carrera E; Schmidt JM; Oddo M; Fernandez L; Claassen J; Seder D; Lee K; Badjatia N; Connolly ES; Mayer SA
    Neurosurgery; 2009 Aug; 65(2):316-23; discussion 323-4. PubMed ID: 19625911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage.
    Polin RS; Bavbek M; Shaffrey ME; Billups K; Bogaev CA; Kassell NF; Lee KS
    J Neurosurg; 1998 Oct; 89(4):559-67. PubMed ID: 9761049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Kessler IM; Pacheco YG; Lozzi SP; de Araújo AS; Onishi FJ; de Mello PA
    Surg Neurol; 2005; 64 Suppl 1():S1:2-5; discussion S1:5. PubMed ID: 15967223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.
    Parra A; Kreiter KT; Williams S; Sciacca R; Mack WJ; Naidech AM; Commichau CS; Fitzsimmons BF; Janjua N; Mayer SA; Connolly ES
    Neurosurgery; 2005 Mar; 56(3):476-84; discussion 476-84. PubMed ID: 15730572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
    Yahia AM; Kirmani JF; Qureshi AI; Guterman LR; Hopkins LN
    Neurocrit Care; 2005; 3(1):16-23. PubMed ID: 16159090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and prognostic value of acute catecholamine surge in patients with aneurysmal subarachnoid hemorrhage.
    Ogura T; Satoh A; Ooigawa H; Sugiyama T; Takeda R; Fushihara G; Yoshikawa S; Okada D; Suzuki H; Araki R; Ishihara S; Nishikawa R; Kurita H
    Neurol Res; 2012 Jun; 34(5):484-90. PubMed ID: 22664172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.